STEP 2 Flashcards
RESTLESS LEG SYNDROME
Uncomfortable urge to move legs with:
Unpleasant sensations in the legs
Onset with inactivity or at night
Relief with movement (eg, walking, stretching)
Risk factors &
associated conditions
RISK FACTORS
Iron deficiency
Uremia
Pregnancy
Diabetes mellitus (especially with neuropathy)
Multiple sclerosis, Parkinson’s disease
Drugs: antidepressants, antipsychotics, antiemetics
NON PHARMACOLOGIC THERAPY
Limit caffeine & alcohol
Regular, moderate exercise
Warm &/or cold soaks or compresses
Medications
MEDICATIONS
Supplemental iron (if serum ferritin <75 ng/mL)
Mild intermittent symptoms: carbidopa-levodopa as needed
Frequent/daily symptoms: α2δ calcium channel ligand (eg, gabapentin, pregabalin)
Dopamine agonists (eg, pramipexole, ropinirole) not preferred
MERALGIA PARESTHETICA
Etiology
Lateral femoral cutaneous nerve entrapment or injury due to:
Compression (eg, tight clothing, obesity, pregnancy)
Iatrogenic injury (eg, total hip arthroplasty)
Clinical features
Paresthesia & ↓ sensation at lateral thigh
Normal motor & reflex examination
Management
Avoidance of tight garments, weight loss
Nonopioid analgesics (eg, NSAIDs)
Anticonvulsants (eg, gabapentin), nerve block, or surgical release for refractory cases
conjunctivitis treatment
Bacterial conjunctivitis
Erythromycin ointment
Polymyxin-trimethoprim drops
Azithromycin drops
Preferred agent in contact lens wearers: fluoroquinolone drops
Viral conjunctivitis
Warm or cold compresses
± Antihistamine/decongestant drops
Allergic conjunctivitis
Over-the-counter antihistamine/decongestant drops for intermittent symptoms
Mast cell stabilizer/antihistamine drops for frequent episodes
A 58-year-old woman comes to the office due to recent-onset tremor, palpitations, weight loss, and fatigue. She has no other medical conditions and takes no medications or over-the-counter supplements. The patient’s mother had hypothyroidism and osteoporosis. Blood pressure is 144/80 mm Hg, pulse is 110/min, and respirations are 18/min. On examination, there is diffuse, nontender enlargement of the thyroid gland. Ocular examination shows bilateral proptosis, lid lag, and periorbital puffiness. The patient has diplopia and ocular discomfort on extremes of lateral gaze. Laboratory tests show a suppressed TSH and elevated thyroid hormone levels. Which of the following treatment options is most likely to worsen this patient’s eye disease?
radioactive IODINE
Complications of Graves disease treatment
Adverse effects
Antithyroid drugs
(thionamides)
Agranulocytosis
Methimazole: 1st-trimester teratogen, cholestasis
Propylthiouracil: hepatic failure, ANCA-associated vasculitis
Radioiodine ablation
Permanent hypothyroidism
Worsening of ophthalmopathy
Possible radiation adverse effects
Surgery
Permanent hypothyroidism
Risk for recurrent laryngeal nerve damage
Risk for hypoparathyroidism
Chronic lymphocytic leukemia
Clinical features
Lymphadenopathy (cervical, supraclavicular, axillary)
Hepatosplenomegaly
Mild thrombocytopenia & anemia
Often asymptomatic
Diagnosis
Severe lymphocytosis & smudge cells
Flow cytometry
Lymph node & bone marrow biopsy not generally needed
Prognosis
Median survival 10 years
Worse prognosis with:
Multiple chain lymphadenopathy
Hepatosplenomegaly
Anemia & thrombocytopenia
Complications
Infection
Autoimmune hemolytic anemia
Secondary malignancies (eg, Richter syndrome)
Clinical features of pulmonary hypertension
Classification
Pulmonary arterial hypertension (WHO group 1)
Due to left heart disease (group 2)
Due to chronic lung disease or hypoxemia (eg, COPD, OSA) (group 3)
Due to chronic thromboembolic disease (group 4)
Due to other causes (eg, sarcoidosis) (group 5)
Symptoms
↓ Cardiac output: exertional syncope/presyncope, fatigue, weakness
↑ PA pressure: chest tightness, hemoptysis (rare)
RV demand ischemia: exertional angina/tightness
Venous congestion: abdominal distension (bowel edema), early satiety
Signs
Precordial heave due to RV hypertrophy
Loud P2, right-sided S3 &/or S4
Holosystolic murmur of tricuspid regurgitation
JVD, ascites, peripheral edema, hepatomegaly
Diffuse alveolar hemorrhage
causes
Pulmonary capillaritis: ANCA vasculitis, SLE, antiphospholipid antibodies
Bland hemorrhage: mitral stenosis, anticoagulation
Alveolar damage: viral pneumonitis, ARDS, drug-induced (eg, cocaine, amiodarone)
Clinical presentation & diagnosis of Diffuse alveolar hemorrhage
Dyspnea, hypoxemia, hemoptysis (absent in ~50%) & blood loss anemia
CXR or CT: diffuse ground-glass opacities
Bronchoscopy: progressive blood on serial lavage
Management of Diffuse alveolar hemorrhage
Treat underlying (eg, rheumatologic, infectious) cause
Supportive care: oxygen, mechanical ventilation; avoid anticoagulation
Glucocorticoid-induced myopathy
Prominent atrophy
Lower extremities most affected
Colon cancer screening
Patients at average risk
Start at age 45:
Colonoscopy every 10 years
gFOBT or FIT every year
FIT-DNA every 1-3 years
CT colonography every 5 years
Flexible sigmoidoscopy every 5 years (or every 10 years with annual FIT)
Patients with FDR with CRC or high-risk adenomatous polyp*
Colonoscopy at age 40 (or 10 years prior to the age of diagnosis in FDR, whichever comes first)
Repeat every 5 years (every 10 years if FDR diagnosed at age >60)
Patients with ulcerative colitis
Start screening 8-10 years after diagnosis
Colonoscopy every 1-3 years
*Adenomatous polyp ≥10 mm, high-grade dysplasia, villous elements (for example).
Initial workup of suspected cognitive impairment
Cognitive testing
MMSE (score <24/30 suggestive of MCI/dementia)
Montreal Cognitive Assessment (score <26/30)
Mini-Cog (abnormal 3-word recall &/or clock-drawing test)
Laboratory testing
Routine: CBC, vitamin B12, TSH, CMP
Selective (specific risk factors): folate, syphilis, vitamin D level
Atypical (early onset): CSF
Imaging
Routine: CT scan or MRI of the brain
Atypical: EEG
CBC = complete blood count; CMP = complete metabolic panel; CSF = cerebrospinal fluid; EEG = electroencephalogram; MCI = mild cognitive impairment; MMSE = Mini-Mental State Examination.
Polymyalgia rheumatica
Clinical features
Rapid-onset pain & stiffness in shoulders & hips ± neck involvement
Fatigue, weight loss, low-grade fever
~10% associated with GCA (eg, headache, jaw claudication, visual symptoms)
Diagnostic testing
Elevated acute-phase markers (eg, ESR, CRP)
Temporal artery biopsy if symptoms of GCA
Treatment
Very rapid response to oral glucocorticoids
Clinical features of androgen abuse
Types of androgens
Exogenous (eg, testosterone replacement therapy)
Synthetic (eg, stanozolol, nandrolone)
Androgen precursors (eg, DHEA)
Side effects/clinical presentation
Reproductive
Men: decreased testicular function & sperm production, gynecomastia
Women: acne, hirsutism, voice deepening, menstrual irregularities
Cardiovascular: left ventricular hypertrophy, possible ↓ HDL & ↑ LDL
Psychiatric: aggressive behavior (men), mood disturbances
Hematologic: polycythemia, possible hypercoagulability
Optic neuritis
Epidemiology
Primarily in young women
Associated with multiple sclerosis
Immune-mediated demyelination
Manifestations
Acute, peaks at 2 weeks
Monocular vision loss
Eye pain with movement
“Washed-out” color vision
Afferent pupillary defect
Diagnosis
MRI of the orbits & brain
Treatment
Intravenous corticosteroids
35% of cases recur